By the same authors

From the same journal

Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales.

Research output: Contribution to journalArticle

Published copy (DOI)



Publication details

JournalJournal of Medical Economics
DateE-pub ahead of print - 13 Jan 2014
DatePublished (current) - 2014
Issue number2
Pages (from-to)111-124
Early online date13/01/14
Original languageEnglish

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations